130 related articles for article (PubMed ID: 38142182)
1. Single center experience using stereotactic body radiation therapy (SBRT) on orthotopic liver transplant protocol for unresectable cholangiocarcinoma.
Wu TC; Deng J; Chu FI; Sadeghi S; Finn R; Agopian VG; Lee P; Raldow AC
HPB (Oxford); 2024 Mar; 26(3):444-450. PubMed ID: 38142182
[TBL] [Abstract][Full Text] [Related]
2. Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A Prospective Pilot Study.
Wong M; Kim J; George B; Eriksen C; Pearson T; Robbins J; Zimmerman MA; Hong JC
J Surg Res; 2019 Oct; 242():23-30. PubMed ID: 31059945
[TBL] [Abstract][Full Text] [Related]
3. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma.
Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y
Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy in the management of oligometastatic and recurrent biliary tract cancer: single-institution analysis of outcome and toxicity.
Franzese C; Bonu ML; Comito T; Clerici E; Loi M; Navarria P; Franceschini D; Pressiani T; Rimassa L; Scorsetti M
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2289-2297. PubMed ID: 32524292
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of pathologic complete response rates for patients with cholangiocarcinoma treated on liver transplant protocols.
Wu TC; Smith CP; Li JS; Burton J; Jackson NJ; Tao R; Ludmir EB; Raldow AC
J Surg Oncol; 2024 Mar; 129(3):574-583. PubMed ID: 37986552
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Gkika E; Hallauer L; Kirste S; Adebahr S; Bartl N; Neeff HP; Fritsch R; Brass V; Nestle U; Grosu AL; Brunner TB
BMC Cancer; 2017 Nov; 17(1):781. PubMed ID: 29162055
[TBL] [Abstract][Full Text] [Related]
7. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma.
Barney BM; Olivier KR; Miller RC; Haddock MG
Radiat Oncol; 2012 May; 7():67. PubMed ID: 22553982
[TBL] [Abstract][Full Text] [Related]
9. [Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma].
Wu YM; Johlin FC; Rayhill SC; Jensen CS; Jin X; Mitros FA
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1155-61. PubMed ID: 20021907
[TBL] [Abstract][Full Text] [Related]
10. [Liver transplantation for irresectable hilar cholangiocarcinoma].
Lai Y; Dong J; Duan W; Yu Q; Meng X; Ye S; Zhang D; Huang Z
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):839-44. PubMed ID: 25604023
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: a single-centre national experience.
Duignan S; Maguire D; Ravichand CS; Geoghegan J; Hoti E; Fennelly D; Armstrong J; Rock K; Mohan H; Traynor O
HPB (Oxford); 2014 Jan; 16(1):91-8. PubMed ID: 23600750
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic body radiotherapy (SBRT) for locally advanced extrahepatic and intrahepatic cholangiocarcinoma.
Sandler KA; Veruttipong D; Agopian VG; Finn RS; Hong JC; Kaldas FM; Sadeghi S; Busuttil RW; Lee P
Adv Radiat Oncol; 2016; 1(4):237-243. PubMed ID: 28740893
[TBL] [Abstract][Full Text] [Related]
13. Outcomes analysis for 280 patients with cholangiocarcinoma treated with liver transplantation over an 18-year period.
Becker NS; Rodriguez JA; Barshes NR; O'Mahony CA; Goss JA; Aloia TA
J Gastrointest Surg; 2008 Jan; 12(1):117-22. PubMed ID: 17963015
[TBL] [Abstract][Full Text] [Related]
14. Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma.
Heimbach JK; Gores GJ; Haddock MG; Alberts SR; Pedersen R; Kremers W; Nyberg SL; Ishitani MB; Rosen CB
Transplantation; 2006 Dec; 82(12):1703-7. PubMed ID: 17198263
[TBL] [Abstract][Full Text] [Related]
15. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
[TBL] [Abstract][Full Text] [Related]
16. Stereotactic body radiotherapy dose and its impact on local control and overall survival of patients for locally advanced intrahepatic and extrahepatic cholangiocarcinoma.
Brunner TB; Blanck O; Lewitzki V; Abbasi-Senger N; Momm F; Riesterer O; Duma MN; Wachter S; Baus W; Gerum S; Guckenberger M; Gkika E
Radiother Oncol; 2019 Mar; 132():42-47. PubMed ID: 30825968
[TBL] [Abstract][Full Text] [Related]
17. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma.
Rana A; Hong JC
Curr Opin Gastroenterol; 2012 May; 28(3):258-65. PubMed ID: 22333563
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant stereotactic body radiation therapy, capecitabine, and liver transplantation for unresectable hilar cholangiocarcinoma.
Welling TH; Feng M; Wan S; Hwang SY; Volk ML; Lawrence TS; Zalupski MM; Sonnenday CJ
Liver Transpl; 2014 Jan; 20(1):81-8. PubMed ID: 24115315
[TBL] [Abstract][Full Text] [Related]
19. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
[TBL] [Abstract][Full Text] [Related]
20. Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma.
Hassoun Z; Gores GJ; Rosen CB
Surg Oncol Clin N Am; 2002 Oct; 11(4):909-21. PubMed ID: 12607579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
